Sulfated galactans from the red seaweed Gracilaria fisheri exerts anti-migration effect on cholangiocarcinoma cells

Phytomedicine. 2017 Dec 1:36:59-67. doi: 10.1016/j.phymed.2017.09.014. Epub 2017 Sep 28.

Abstract

Background: Seaweeds have a long history of use in Asian countries as functional foods, medicinal herbs, and the treatment of cancer. Polysaccharides from various seaweeds have shown anti-tumor activity. Cholangiocarcinoma (CCA), often with metastatic disease, is highly prevalent in Thailand as a consequence of liver fluke infection. Recently, we extracted sulfated galactans (SG) from Gracilaria fisheri (G. fisheri), a south east Asian seaweed, and found it exhibited anti-proliferation effect on CCA cells.

Purpose: In the present study, we evaluated the anti-migration activity of SG on CCA cells and its underlined mechanism.

Methods: CCA cells were treated with SG alone or drugs targeting to epidermal growth factor (EGF) receptor (EGFR) or pretreated with SG prior to incubation with EGF. Anti-migration activity was determined using a scratch wound-healing assay and zymography. Immunofluorescence staining and western blotting were used to investigate EGFR signaling mediators.

Results: Under basal condition, SG reduced the migration rate of CCA, which was correlated with a decrease in the active-form of matrix metalloproteinases-9. SG decreased expression of phosphorylated focal adhesion kinase (FAK), but increased expression of E-cadherin to promote cells stasis. Moreover, phosphorylation of EGFR and extracellular signal-regulated kinases (ERK), known to stimulate growth of cancer cells, was blocked in a comparable way to EGFR inhibitors Cetuximab and Erlotinib. Pretreatment cells with SG attenuated EGF induced phosphorylation of EGFR, ERK and FAK.

Conclusion: This study reveals that SG from G. fisheri retards migration of CCA cells, and its mechanism of inhibition is mediated, to some extent, by inhibitory effects on MAPK/ERK signal transduction pathway. Our findings suggest that there may be a therapeutic potential of SG in CCA treatment.

Keywords: Anti-migration; Cholangiocarcinoma; Epidermal growth factor receptor; Gracilaria fisheri; Mitogen-activated kinases/extracellular signal-regulated kinases; Sulfated galactans.

MeSH terms

  • Antigens, CD
  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Bile Duct Neoplasms / drug therapy*
  • Bile Duct Neoplasms / metabolism
  • Bile Duct Neoplasms / pathology
  • Cadherins / metabolism
  • Cell Movement / drug effects
  • Cholangiocarcinoma / drug therapy*
  • Cholangiocarcinoma / metabolism
  • Cholangiocarcinoma / pathology
  • Epidermal Growth Factor / metabolism
  • ErbB Receptors / metabolism
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Focal Adhesion Kinase 1 / metabolism
  • Galactans / chemistry
  • Galactans / pharmacology*
  • Gracilaria / chemistry*
  • Humans
  • Phosphorylation / drug effects
  • Seaweed / chemistry
  • Signal Transduction / drug effects
  • Tumor Cells, Cultured

Substances

  • Antigens, CD
  • Antineoplastic Agents, Phytogenic
  • CDH1 protein, human
  • Cadherins
  • Galactans
  • Epidermal Growth Factor
  • EGFR protein, human
  • ErbB Receptors
  • Focal Adhesion Kinase 1
  • PTK2 protein, human
  • Extracellular Signal-Regulated MAP Kinases